Most Popular Stories
- GSK, Takeda say nay to in-house diagnostics units
- EMC to found Russian cloud computing, 'Big Data' hub
- Being more like Coca-Cola takes days out of GSK's pharma supply chain
- Merck says Victrelis can interfere with HIV meds
- Psychologists petition against DSM-5 revisions
- WellPoint to drop branded Lipitor from its formulary
Webinars
- Prepare Your Compliance Systems and Processes for the Physician Payments Sunshine ActBeginning in 2012, pharmaceutical, biotechnology and medical device companies will be requ
- Active Directory & the Cloud for Biotech & PharmaBiotech and pharmaceutical companies are leaders cloud/SaaS technology adoption. This webi
- Webinar: Next Gen Sequencing from FFPE SamplesNext generation sequencing (NGS) technologies hold enormous promise to advance personalize
- Drug Development: An Overview of the Regulated Clinical Trials Process Used to Bring a New Drug to MarketJoin us for a one-hour overview of the regulated clinical trials process used to bring a n
Featured Jobs
-
Product Manager, Channel Marketing Job
Celgene Corporation - Summit, NJ, US -
Clinical Research Associate
Jennerex, Inc - San Francisco, CA -
Docket Clerk Job
Celgene Corporation - Summit, NJ, US -
Sr. Manager, Market Research Job
Celgene Corporation - Summit, NJ, US -
Director Marketing Communications
Bailey Search & Associates - Boston, MA
Events
- DCAT Week 2012
Mar 12-15 — New York City - DCAT Week '12 Biologics Forum & Networking Reception
Mar 14 — New York City - BioNetwork East: Key BioPharma Partnering Conference
March 5-7 2012 — Miami, Florida - Just Released: New Trends in Preventive and Therapeutic Vaccine
Free Newsletter
FierceBiotech is the biotech industry's daily monitor, with a special focus on drug discovery and clinical trials. Keep up to speed with the latest biotechnology trends, breakthroughs and FDA approval news. Join 90,000+ biotechnology and pharma industry professionals who get FierceBiotech via daily email. Sign up today!
Popular Topics
Whitepapers
- Central Nervous System (CNS) Compound Library from OTAVA
- Launching a Medical Device, Healthcare or Life Science Product: Fail Fast, Marginal or Worth Pursuing?
- The Cutting Edge of Chemistry
- API in Capsule: Common "First in Man" approaches vs. The Lost Art of Formulation Development
- New MicroMass Study of Social Media Behavior Offers Connection Planning Insights for Healthcare Marketers
- Avoiding Post-Acquisition Product Sales Failures
Should drug and medical device makers be required to report payments made to doctors?
Yes
79%
No
21%
Total votes: 159
